FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Valproate Sodium Injection, USP
Status: Currently in Shortage
»Date first posted: 12/30/2020
»Therapeutic Categories: Neurology

Expand all

Fresenius Kabi USA, LLC (New 12/30/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg per 5 mL (100 mg per mL) (NDC 63323-494-05) Backordered. Next release February 2021. Manufacturing delays

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (New 12/30/2020)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg/mL, 5 mL vial (NDC 0143-9785-10) This presentation is temporarily on backorder. Lots are scheduled for manufacturing and will be available at the end of December. Additional lots will be available in the January – February 2021 timeframe. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English